New insights into If inhibition: from ischemia prevention to improvement in coronary outcomes
Editorial
- If inhibition: breaking new ground in the treatment of stable coronary artery disease. Inhibition du courant If : une innovation dans le traitement de la maladie coronaire stable
R. Ferrari and K. Fox, Italy and United Kingdom
Themed articles
- The global burden of coronary heart disease
G. G. De Backer, Belgium - Heart rate: from risk marker to risk factor in coronary artery disease
J. S. Borer, USA - Elevated heart rate and atherosclerosis: pathophysiology and clinical outcomes
M. Böhm, J.-C. Reil, and F. Custodis, Germany - Is heart rate optimally controlled in patients with coronary artery disease in clinical practice?
C. Daly, Ireland - The place of ivabradine in the management of patients with CAD: new insights
P. G. Steg and G. Ducrocq, France - Lessons from BEAUTIFUL: new frontiers in heart rate control
Å. Hjalmarson, Sweden - Optimizing secondary prevention treatment in stable coronary artery disease
L. R. Padial, Spain
Controversial Question
- To what extent has monitoring of heart rate reduction in your coronary patients become part of your daily practice?
M. Al-Anazi, Saudi Arabia – E. Alegria, Spain – P. Brugada and L. Capulzini, Belgium – A. M. Dart, Australia – L. M. M. Gonçalves, Portugal – B. Gorenek, Turkey – J. A. Kragten, The Netherlands – G. M. C. Rosano and C. Vitale, Italy – U. Thadani, USAN
PROCORALAN
- Clinical benefits of pure heart rate reduction with Procoralan: evidence and perspectives
I. Elyubaeva, France
Interview
- The clinical implication of pure heart rate reduction in CAD management: future directions
K. Fox, United Kingdom
Focus
- Recommendations on how to measure resting heart rate
P. Palatini, Italy
Update
- Prevention of endothelial dysfunction with pure heart rate reduction
J. Yang and J.-C. Tardif, Canada
A Touch of France
- The heart of the kings of France: “cordial immortality”
C. Régnier, France - The Cathedral Basilica of Saint-Denis
I. Spaak, France